Company Profile
Aura Biosciences Stock Price, News & Analysis
- Ticker:
- AURA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
7.72 USD (+7.52%)
Close
Last updated: August 6, 2026
713M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, AURA closed up 7.52% at $7.72. No new same-company headline was identified in the current news window.
Company overview
Business overview
Aura Biosciences is a biotechnology company focused on precision oncology and tumor-targeting therapies. Its story is built around using targeted biologics to deliver treatment specifically to tumors.
Geographic Base and Sector Classification
Aura Biosciences is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
Business Model Characteristics
The company depends on clinical data, translational validation, and the ability to develop a narrow but differentiated cancer pipeline. Investors usually watch efficacy, safety, and strategic milestones.
Position Within the Biotechnology Landscape
Aura occupies a precision-oncology niche within biotech. It is catalyst-sensitive because the market needs evidence that the targeted approach can create real clinical value.
Future catalysts
Aura Biosciences’s catalysts are bel-sar and the ocular-oncology platform, where the next clinical update can materially change the story. The market cares about whether the platform keeps differentiating itself.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Aura Biosciences (AURA)?
Aura Biosciences (AURA) most recently closed at 7.72 USD, a +7.52% move versus the previous session.
What is the market cap of Aura Biosciences (AURA)?
Aura Biosciences currently has a market capitalization of 713M USD on BioPharmSignal.
What does Aura Biosciences do?
Aura Biosciences is a biotechnology company focused on precision oncology and tumor-targeting therapies. Its story is built around using targeted biologics to deliver treatment specifically to tumors.
On which exchange is AURA stock listed?
Aura Biosciences (AURA) is associated with NASDAQ, United States, Biopharma.
What is Aura?
Aura Biosciences’s catalysts are bel-sar and the ocular-oncology platform, where the next clinical update can materially change the story.
Which conditions is Aura Biosciences targeting with Aura?
Aura Biosciences is associated with oncology based on its company overview and current catalyst commentary.
How does Aura Biosciences describe recent progress with Aura?
Aura Biosciences’s catalysts are bel-sar and the ocular-oncology platform, where the next clinical update can materially change the story.
What is Biosciences?
Aura Biosciences is a biotechnology company focused on precision oncology and tumor-targeting therapies.